Scotiabank Maintains Sector Perform on Sabra Health Care REIT, Raises Price Target to $15
Portfolio Pulse from Benzinga Newsdesk
Scotiabank analyst Nicholas Yulico maintains a Sector Perform rating on Sabra Health Care REIT (NASDAQ:SBRA) and raises the price target from $14 to $15.
May 15, 2024 | 2:47 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Scotiabank analyst Nicholas Yulico maintains a Sector Perform rating on Sabra Health Care REIT and raises the price target from $14 to $15.
The raised price target from $14 to $15 by Scotiabank indicates a positive outlook on Sabra Health Care REIT's stock, which could lead to a short-term price increase. However, the Sector Perform rating suggests moderate performance relative to peers.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100